READER QUESTIONS:
Apply This HCPCS Code for Cancer Drug
Published on Mon Aug 17, 2009
Question: My practice employs an oncology ob-gyn, and I heard CMS released a new HCPCS code for a cancer drug. What is it, and how much will Medicare reimburse? Texas Subscriber Answer: CMS did release a HCPCS code for Bevacizumab, a cancer drug. The new code will be effective as of Oct. 1: • Q2024 -- Injection, Bevacizumab, 0.25 mg This drug is used in combination with other chemoagents or treatments to stop the body from forming new blood cells that could otherwise feed a tumor. Physicians can use this drug with metastatic cancer only, and in 2008, the Food and Drug Administration (FDA) approved this drug for the treatment of metastatic breast cancer. Prior to that, the FDA approved it only for the treatment of metastic colon and non-small cell lung cancers. Recent studies indicate that this drug in combination with a second drug may be an effective treatment for [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
